• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Slides for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee

 

Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
 
FDA
  
FDA Presentations for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 301KB)
 
 
Biomedical Advanced Research and Development Authority
 
BARDA Presentations for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 360KB)
 
 
Centers for Disease Control and Prevention Speaker Slides
  
Linda J. Neff, Ph.D.,M.S.P.H, Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 1.99MB)
 
 
Minnesota Department of Health Speaker Slides
  
Ruth Lynfield, M.D., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 188KB)
 
 
Department of Homeland Security Speaker Slides
  
Susan Coller-Monarez, Ph.D., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 477KB)
 
 
Associations’ Speakers Slides
  
Robert R. Bass, M.D., FACEP, Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 410KB)
 
James J. James, M.D., Dr.P.H., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 123KB)
 
John Bradley, M.D., Presentation for the April 2, 2012 Joint Meeting of the Anti-Infective Drugs Advisory Committee and Nonprescription Drugs Advisory Committee (PDF – 196KB)